UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
November 7, 2005
Date of Report (Date of earliest event reported)
NeoRx Corporation
(Exact Name of Registrant as Specified in Charter)
Washington |
| 0-16614 |
| 91-1261311 |
(State or Other Jurisdiction |
| (Commission File No.) |
| (IRS Employer |
of Incorporation) |
|
|
| Identification No.) |
|
|
|
|
|
300 Elliott Avenue West, Suite 500, Seattle, WA |
| 98119-4114 | ||
(Address of principal executive offices) |
| (Zip Code) | ||
(206) 281-7001
(Registrant’s telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Section 8 – Other Events
Item 8.01. | Other Events. |
On November 7, 2005, the FDA granted the Company’s request for orphan drug designation of picoplatin (NX 473) for treatment of small cell lung cancer. See press release attached hereto as Exhibit 99.1 and incorporated herein by reference.
Item 9.01. | Financial Statements and Exhibits. |
|
|
(d) | Exhibits. |
|
|
| 99.1 - Press release dated November 10, 2005. |
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NeoRx Corporation | ||
|
|
| |
Dated: November 10, 2005 | By: | s/ Susan D. Berland |
|
|
| Name: Susan D. Berland | |
|
| Title: Chief Financial Officer | |
3
EXHIBIT INDEX
Exhibit No. |
| Description |
99.1 |
| Press Release dated November 10, 2005 |
4